Eduard is a leading expert in gene therapy and viral vector platforms. He was the Founder and CEO of DINAMIQS since 2021and became Chief Technology Officer when the company was acquired by Siegfried in 2023. Previously, he was CTO of DiNAQOR, a gene therapy company focused on cardiac and kidney therapies. Earlier, he was Head of Innovative Vectorology at the French National Institute of Health and Medical Research (INSERM) and Scientific Director of the Translational Vector Core at University of Nantes. ​

In the past he was vice-president of the SFTCG and chairman of the Manufacturing Committee of the ESGCT.​

Eduard has a PhD in Biochemistry and Molecular Biology and a DVM from the Autonomous University of Barcelona.